RESUMEN
Ayahuasca is a psychoactive plant brew containing dimethyltryptamine (DMT) and monoamine oxidase inhibitors (MAOIs). It originates from the Amazon basin, where it is used primarily for ceremonial purposes. Ayahuasca tourists are now entering certain communities seeking alternative physical or psychological healing, as well as spiritual growth. RATIONALE: Recent evidence has shown that the similar acting psychedelic compound, psilocybin, facilitated long-term increases in trait openness following a single administration. OBJECTIVES: This paper assesses the impact of ayahuasca on personality in a traditional framework catering for ayahuasca tourists. METHOD: Within a mixed design, we examined the effect of ayahuasca on participants' personality (measured by the NEO Personality Inventory 3 questionnaire) across time (pre- to post-ayahuasca administration, and 6-month follow-up), relative to a comparison group (who did not ingest ayahuasca). RESULTS: The results demonstrated significant increases in agreeableness pre- and post-ayahuasca administration and significant reductions in neuroticism in 24 participants, relative to the comparison group. Both of these changes were sustained at 6-month follow-up, and trait level increases were also observed in openness at this stage. Additionally, greater perceived mystical experience (measured using the Mystical Experience Questionnaire 30) was associated with increased reductions in neuroticism. CONCLUSIONS: These findings, which indicate a positive mediating effect of ayahuasca on personality, support the growing literature suggesting potential therapeutic avenues for serotonergic psychedelics.
Asunto(s)
Banisteriopsis , Alucinógenos/farmacología , Turismo Médico/psicología , Neuroticismo/efectos de los fármacos , Personalidad/efectos de los fármacos , Extractos Vegetales/farmacología , Adulto , Banisteriopsis/química , Femenino , Estudios de Seguimiento , Alucinógenos/aislamiento & purificación , Humanos , Masculino , Turismo Médico/tendencias , Inhibidores de la Monoaminooxidasa/aislamiento & purificación , Inhibidores de la Monoaminooxidasa/farmacología , Misticismo/psicología , N,N-Dimetiltriptamina/aislamiento & purificación , N,N-Dimetiltriptamina/farmacología , Neuroticismo/fisiología , Personalidad/fisiología , Perú/epidemiología , Extractos Vegetales/aislamiento & purificación , Psilocibina/aislamiento & purificación , Psilocibina/farmacología , Encuestas y CuestionariosRESUMEN
Harmine is a natural ß-carboline alkaloid found in several botanical species, such as the Banisteriopsis caapi vine used in the preparation of the hallucinogenic beverage ayahuasca and the seeds of Syrian rue (Peganum harmala). Preclinical studies suggest that harmine may have neuroprotective and cognitive-enhancing effects, and retrospective/observational investigations of the mental health of long-term ayahuasca users suggest that prolonged use of this harmine-rich hallucinogen is associated with better neuropsychological functioning. Thus, in order to better investigate these possibilities, we performed a systematic literature review of preclinical studies analyzing the effects of harmine on hippocampal neurons and in memory-related behavioral tasks in animal models. We found two studies involving hippocampal cell cultures and nine studies using animal models. Harmine administration was associated with neuroprotective effects such as reduced excitotoxicity, inflammation, and oxidative stress, and increased brain-derived neurotrophic factor (BDNF) levels. Harmine also improved memory/learning in several animal models. These effects seem be mediated by monoamine oxidase or acetylcholinesterase inhibition, upregulation of glutamate transporters, decreases in reactive oxygen species, increases in neurotrophic factors, and anti-inflammatory effects. The neuroprotective and cognitive-enhancing effects of harmine should be further investigated in both preclinical and human studies.
Asunto(s)
Banisteriopsis/química , Alucinógenos/farmacología , Harmina/farmacología , Animales , Cognición/efectos de los fármacos , Alucinógenos/aislamiento & purificación , Harmina/aislamiento & purificación , Hipocampo/efectos de los fármacos , Humanos , Memoria/efectos de los fármacos , Fármacos Neuroprotectores/aislamiento & purificación , Fármacos Neuroprotectores/farmacologíaRESUMEN
Use of unauthorized synthetic drugs is a serious, forensic, regulatory and public health issue. In this scenario, consumption of drug-impregnated blotters is very frequent. For decades, blotters have been generally impregnated with the potent hallucinogen known as lysergic acid diethylamide (LSD); however, since 2013 blotter stamps with N-2 methoxybenzyl-substituted phenylethylamine hallucinogen designated as "NBOMes" have been seized in Chile. To address this issue with readily accessible laboratory equipment, we have developed and validated a new HPTLC method for the identification and quantitation of 25-C-NBOMe in seized blotters and its confirmation by GC-MS. The proposed method was validated according to SWGTOX recommendations and is suitable for routine analysis of seized blotters containing 25-C-NBOMe. With the validated method, we analyzed 15 real samples, in all cases finding 25-C-NBOMe in a wide dosage range (701.0-1943.5 µg per blotter). In this situation, we can assume that NBOMes are replacing LSD as the main hallucinogenic drug consumed in blotters in Chile.
Asunto(s)
Cromatografía en Capa Delgada/normas , Cromatografía de Gases y Espectrometría de Masas/normas , Alucinógenos/aislamiento & purificación , Drogas Ilícitas/aislamiento & purificación , Fenetilaminas/aislamiento & purificación , Administración Sublingual , Adsorción , Chile , Cromatografía en Capa Delgada/métodos , Humanos , Papel , Reproducibilidad de los Resultados , Sensibilidad y EspecificidadRESUMEN
Recently, the anti-addictive potential of ayahuasca, a dimethyltryptamine(DMT)- and ß-carboline-rich hallucinogenic beverage traditionally used by indigenous groups of the Northwest Amazon and currently by syncretic churches worldwide, has received increased attention. To better evaluate this topic, we performed a systematic literature review using the PubMed database to find quantitative studies (using statistical analysis) that assessed the effects of ayahuasca or its components in drug-related symptoms or disorders. We found five animal studies (using harmaline, harmine, or ayahuasca) and five observational studies of regular ayahuasca consumers. All animal studies showed improvement of biochemical or behavioral parameters related to drug-induced disorders. Of the five human studies, four reported significant reductions of dependence symptoms or substance use, while one did not report significant results. The mechanisms responsible for the anti-addictive properties of ayahuasca and its alkaloids are not clarified, apparently involving both peripheral MAO-A inhibition by the ß-carbolines and central agonism of DMT at 5-HT2A receptors expressed in brain regions related to the regulation of mood and emotions. Although results are promising, controlled studies are needed to replicate these preliminary findings.
Asunto(s)
Banisteriopsis/química , Extractos Vegetales/farmacología , Trastornos Relacionados con Sustancias/tratamiento farmacológico , Alcaloides/aislamiento & purificación , Alcaloides/farmacología , Animales , Alucinógenos/aislamiento & purificación , Alucinógenos/farmacología , Humanos , Extractos Vegetales/químicaRESUMEN
Salvia divinorum is a perennial sage native to Oaxaca, Mexico, that has been used traditionally in divination rituals and as a treatment for the "semimagical" disease panzón de borrego. Because of the intense "out-of-body" experiences reported after inhalation of the pyrolized smoke, S. divinorum has been gaining popularity as a recreational hallucinogen, and the United States and several other countries have regulated its use. Early studies isolated the neoclerodane diterpene salvinorin A as the principal psychoactive constituent responsible for these hallucinogenic effects. Since the finding that salvinorin A exerts its potent psychotropic actions through the activation of KOP receptors, there has been much interest in elucidating the underlying mechanisms behind its effects. These effects are particularly remarkable, because 1) salvinorin A is the first reported non-nitrogenous opioid receptor agonist, and 2) its effects are not mediated by the 5-HT(2A) receptor, the classic target of hallucinogens such as lysergic acid diethylamide and mescaline. Rigorous investigation into the structural features of salvinorin A responsible for opioid receptor affinity and selectivity has produced numerous receptor probes, affinity labels, and tools for evaluating the biological processes responsible for its observed psychological effects. Salvinorin A has therapeutic potential as a treatment for pain, mood and personality disorders, substance abuse, and gastrointestinal disturbances, and suggests that nonalkaloids are potential scaffolds for drug development for aminergic G-protein coupled receptors.
Asunto(s)
Diterpenos de Tipo Clerodano/farmacología , Alucinógenos/farmacología , Receptores Opioides kappa/efectos de los fármacos , Animales , Diterpenos de Tipo Clerodano/química , Diterpenos de Tipo Clerodano/aislamiento & purificación , Diseño de Fármacos , Etnofarmacología , Alucinógenos/química , Alucinógenos/aislamiento & purificación , Humanos , Medicina Tradicional , México , Unión Proteica , Receptores Opioides kappa/metabolismo , Salvia/química , Relación Estructura-ActividadRESUMEN
Recent attention to the monoamine oxidase inhibiting properties of Banisteriopsis caapi's harmala alkaloids has precluded a balanced assessment of B. caapi's overall significance to indigenous South American societies. Relatively little attention has been paid to the cultural contexts, local meanings and patterns of use of B. caapi among snuff-using societies, such as the Piaroa, who do not prepare decoctions containing N,N-dimethyltryptamine (DMT) admixtures. This article reviews the psychopharmacological literature on B. caapi in light of recent ethnographic work conducted among the Piaroa of southern Venezuela. Piaroa shamans use only B. caapi's cambium, identify at least five distinct varieties of B. caapi, and emphasise the plant's importance for heightening empathy. Some Piaroa people also attribute a range of extra-shamanic uses to B. caapi, including as a stimulant and hunting aid. In light of the psychopharmacological complexity of harmala alkaloids, and ethnographic evidence for a wide range of B. caapi uses,future research should reconsider B. caapi's cultural heritage and psychopharmacological potential as a stimulant and antidepressant-like substance.
Asunto(s)
Alcaloides/farmacología , Banisteriopsis/química , Extractos Vegetales/farmacología , Banisteriopsis/clasificación , Alucinógenos/aislamiento & purificación , Alucinógenos/farmacología , Humanos , Indígenas Sudamericanos , Medicina Tradicional , Inhibidores de la Monoaminooxidasa/aislamiento & purificación , Inhibidores de la Monoaminooxidasa/farmacología , N,N-Dimetiltriptamina/aislamiento & purificación , N,N-Dimetiltriptamina/farmacología , Extractos Vegetales/química , Chamanismo , VenezuelaRESUMEN
Salvinorin C (1), a minor component from a biologically active TLC fraction, was isolated from the leaves of the Mexican mint Salvia divinorum. Its structure was elucidated on the basis of extensive proton and C-13 NMR experiments, as well as by comparison of the NMR data with those of the mono- and diacetate derivatives 5-7 of the major NaBH(4)-reduction product of salvinorin A (2). [structure: see text]